rs5177 |
chr1 |
53711735 |
0.000081 |
G |
C |
Bipolar disorder and schizophrenia |
LRP8 |
UTR-3 |
20889312
|
rs5177 |
chr1 |
53711735 |
0.00005 |
G |
C |
Schizophrenia |
LRP8 |
UTR-3 |
pha002857
|
rs5176 |
chr1 |
53711809 |
3.44e-37 |
T |
G |
LDL cholesterol |
LRP8 |
UTR-3 |
23063622
|
rs5176 |
chr1 |
53711809 |
5.12e-52 |
T |
G |
HDL cholesterol |
LRP8 |
UTR-3 |
23063622
|
rs5176 |
chr1 |
53711809 |
6.51e-78 |
T |
G |
Cholesterol,total |
LRP8 |
UTR-3 |
23063622
|
rs5176 |
chr1 |
53711809 |
8.86e-21 |
T |
G |
Triglycerides |
LRP8 |
UTR-3 |
23063622
|
rs5174 |
chr1 |
53712727 |
0.000034 |
C |
T |
Schizophrenia |
LRP8 |
missense |
21791550
|
rs5174 |
chr1 |
53712727 |
0.000000094 |
C |
T |
Psychosis |
LRP8 |
missense |
23164818
|
rs10788950 |
chr1 |
53713336 |
0.00055 |
A |
G |
Response to taxane treatment (placlitaxel) |
LRP8 |
intron |
23006423
|
rs11206127 |
chr1 |
53713549 |
0.0000425 |
G |
A |
Bipolar disorder and schizophrenia |
LRP8 |
intron |
20889312
|
rs11206127 |
chr1 |
53713549 |
0.0000316 |
G |
A |
Schizophrenia |
LRP8 |
intron |
pha002857
|
rs869987 |
chr1 |
53723190 |
0.0000386 |
G |
T |
Bipolar disorder and schizophrenia |
LRP8 |
intron |
20889312
|
rs869987 |
chr1 |
53723190 |
0.0000454 |
G |
T |
Schizophrenia |
LRP8 |
intron |
pha002857
|
rs869988 |
chr1 |
53723349 |
0.0000585 |
T |
C |
Bipolar disorder and schizophrenia |
LRP8 |
intron |
20889312
|
rs2297661 |
chr1 |
53723965 |
0.00000038 |
C |
G |
Cholesterol,total |
LRP8 |
intron |
23063622
|
rs1288489 |
chr1 |
53772544 |
0.00016 |
C |
G |
Type 2 diabetes |
LRP8 |
intron |
17463246
|
rs2788032 |
chr1 |
53777631 |
0.000006 |
A |
C |
Body mass index (interaction) |
LRP8 |
intron |
23192594
|
rs2788032 |
chr1 |
53777631 |
0.000118 |
A |
C |
Amyotrophic lateral sclerosis (sporadic) |
LRP8 |
intron |
24529757
|
rs872314 |
chr1 |
53787483 |
0.00000592 |
A |
G |
Multiple complex diseases |
LRP8 |
intron |
17554300
|
rs3820198 |
chr1 |
53792651 |
0.000027 |
A |
C |
Alcohol dependence |
LRP8 |
missense |
22096494
|